270 related articles for article (PubMed ID: 37108648)
1. Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling.
Sîrbe C; Badii M; Crişan TO; Bența G; Grama A; Joosten LAB; Rednic S; Pop TL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108648
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.
Kerkar N; Chan A
Clin Liver Dis; 2018 Nov; 22(4):689-702. PubMed ID: 30266157
[TBL] [Abstract][Full Text] [Related]
6. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
7. Paediatric Autoimmune Liver Disease.
Liberal R; Vergani D; Mieli-Vergani G
Dig Dis; 2015; 33 Suppl 2():36-46. PubMed ID: 26641670
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune hepatitis in children: what is different from adult AIH?
Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis.
Kemme S; Mack CL
Pediatr Clin North Am; 2021 Dec; 68(6):1293-1307. PubMed ID: 34736590
[TBL] [Abstract][Full Text] [Related]
10. Top-Down Proteomics Detection of Potential Salivary Biomarkers for Autoimmune Liver Diseases Classification.
Olianas A; Guadalupi G; Cabras T; Contini C; Serrao S; Iavarone F; Castagnola M; Messana I; Onali S; Chessa L; Diaz G; Manconi B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674470
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
12. Profiling of mouse and human liver diseases identifies targets for therapeutic treatment of autoimmune hepatitis.
Centa M; Thermidor C; Fiel MI; Alexandropoulos K
Clin Immunol; 2023 Nov; 256():109807. PubMed ID: 37821072
[TBL] [Abstract][Full Text] [Related]
13. The role of complement activation in autoimmune liver disease.
Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA
Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403
[TBL] [Abstract][Full Text] [Related]
14. Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis.
Junge N; Tiedau M; Verboom M; Hallensleben M; Blasczyk R; Schlue J; Goldschmidt I; Pfister ED; Baumann U
Eur J Pediatr; 2016 Apr; 175(4):527-37. PubMed ID: 26567543
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and Adolescents.
Ferri PM; Simões E Silva AC; Torres KCL; Silva SLC; Aquino DJQ; Ferreira MLM; Fagundes EDT; Miranda DM; Ferreira AR
J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):204-211. PubMed ID: 29045346
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune paediatric liver disease.
Mieli-Vergani G; Vergani D
World J Gastroenterol; 2008 Jun; 14(21):3360-7. PubMed ID: 18528933
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents.
Rojas CP; Bodicharla R; Campuzano-Zuluaga G; Hernandez L; Rodriguez MM
Fetal Pediatr Pathol; 2014 Aug; 33(4):202-9. PubMed ID: 24754367
[TBL] [Abstract][Full Text] [Related]
19. Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome.
Di Giorgio A; Hadzic N; Dhawan A; Deheragoda M; Heneghan MA; Vergani D; Mieli-Vergani G; Samyn M
J Pediatr; 2020 Mar; 218():121-129.e3. PubMed ID: 31955873
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune hepatitis from the paediatric perspective.
Roberts EA
Liver Int; 2011 Nov; 31(10):1424-31. PubMed ID: 22093323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
